<?xml version="1.0" encoding="UTF-8"?>
<p id="Par60">All patients had compensated liver disease according to the Child–Pugh classification. Group A subjects showed a higher FIB-4 score (2.2 vs. 1.6, 
 <italic>p</italic> = 0.009). No differences in liver stiffness and fibrosis stage distribution, APRI/MELD score, and HCV-RNA at baseline were observed between the two groups.
</p>
